Related by context. All words. (Click for frequent words.) 81 Rotavirus Vaccine 79 Prostate Cancer Vaccine 77 Seasonal Influenza Vaccine 77 Combination Treatment 77 Shingles Vaccine 77 Chronic Hepatitis B 76 Epilepsy Drug 76 Smallpox Vaccine 76 Prolongs Survival 75 Cervical Cancer Vaccine 75 Influenza Vaccine 75 IND Application 75 Schizophrenia Drug 75 Blood Thinner 75 Advanced Melanoma 75 Pandemic Flu Vaccine 74 Antiviral Drugs 74 Bird Flu Vaccine 74 Cholesterol Lowering Drug 74 Lung Cancer Drug 74 Cholesterol Drug 74 Appears Safe 74 Arthritis Drug 74 Investigational Treatment 74 Long Term Efficacy 74 Blood Pressure Drug 74 Proves Effective 74 Pneumococcal Vaccine 73 Slow Progression 73 Lupus Drug 73 Asthma Treatment 73 Rheumatoid Arthritis Drug 73 Single Dose 73 Million Doses 73 Improves Survival 73 Gout Drug 73 Avian Flu Vaccine 73 FDA Approvals 73 Osteoporosis Drug 73 Meningitis Vaccine 73 Vaccine Candidate 73 Antiviral Drug 73 Receives Orphan Drug Designation 73 Drug Candidate 73 FDA Okays 73 Drug Shows Promise 73 Phase III Trials 73 Seasonal Flu Vaccine 73 Fungal Infections 73 Recombinant Human 73 Drug Combo 73 Liver Failure 73 Cholesterol Drugs 73 Study Evaluating 73 Pediatric Patients 73 Proven Effective 73 Gastric Cancer 73 Severe Sepsis 72 Anemia Drug 72 Drug Fails 72 Stronger Warnings 72 Weight Loss Drug 72 Phase IIb Trial 72 Pooled Analysis 72 Investigational Compound 72 Potentially Fatal 72 Statin Drugs 72 Treating Chronic 72 Anticancer Drug 72 Phase 2b Trial 72 Improve Survival 72 Drug Maker 72 Data Suggest 72 Rotavirus Vaccines 72 Patients Treated With 72 Improves Outcomes 72 Kidney Transplant Patients 72 Osteoporosis Treatment 72 Hepatocellular Carcinoma 72 Drug Resistant 72 Beneficial Effects 72 Combination Vaccine 72 Premature Infants 72 Colorectal Cancer Patients 72 Efficacious 72 Measles Vaccine 72 Novel Antibiotic 72 Malaria Vaccine 72 Improved Survival 72 Nicotine Vaccine 72 Cholesterol Lowering 72 Cell Transplants 72 Begin Clinical Trials 72 Epilepsy Drugs 72 Lung Cancer Patients 72 Diabetic Patients 72 Flu Virus 72 Clinical Trial Evaluating 72 FDA Approves Drug 71 Potent Antiviral Activity 71 Swine Flu Vaccines 71 Psoriasis Drug 71 Immune Cells 71 Allergic Reactions 71 Shows Efficacy 71 Survival Benefit 71 Heartburn Drugs 71 Crit Rev 71 Rheumatoid Arthritis Patients 71 Generic Versions 71 Clinical Trial Results 71 Erectile Dysfunction Drug 71 Antipsychotic Drugs 71 Vaccine Shows Promise 71 FDA Accepts 71 Drug Combinations 71 Intravenous Formulation 71 Demonstrates Efficacy 71 Glatiramer Acetate 71 Phase 2a Trial 71 Migraine Drug 71 Combo Therapy 71 Overactive Bladder 71 Hypertensive Patients 71 Antitumor Activity 71 Guidelines Issued 71 FDA Warns Against 71 Advanced Colorectal Cancer 71 Adjuvant Treatment 71 Inflammatory Markers 71 Pulmonary Arterial Hypertension 71 Genital Herpes 71 Metastatic Colorectal Cancer 71 Fewer Side Effects 71 Phase III Trial 71 Meets Primary Endpoint 71 Pain Relievers 71 Completes Patient Enrollment 71 Cocaine Addiction 71 Vaccine Protects Against 71 Antidepressant Drug 71 Flu Vaccines 71 Study Shows Benefits 71 Prolongs Life 71 Renal Cell Carcinoma 71 Previously Treated 71 Generic Version 70 Inhaled Insulin 70 Investigational Agent 70 Pharmacokinetic Study 70 Diagnostic Tests 70 Pandemic Influenza Vaccine 70 Transdermal Patch 70 Phase 2b Clinical Trial 70 Treatment Shows Promise 70 Sinus Infections 70 Osteoporosis Drugs 70 Rabies Vaccine 70 Antitumor 70 Heart Stents 70 Newly Diagnosed Multiple Myeloma 70 Gene Variant 70 Stem Cell Treatment 70 Interferon Alpha 70 Influenza Virus 70 Infected Patients 70 Polio Vaccine 70 Obesity Linked 70 Lowers Risk 70 Reduced Risk 70 Antiepileptic Drug 70 TB Vaccine 70 Flu Strain 70 Multiple Myeloma Patients 70 Bipolar Mania 70 FDA Panel Recommends 70 Myeloma Patients 70 Mylan Receives Approval 70 Anticoagulant 70 CDC Recommends 70 Transplant Patients 70 Drug Regimen 70 Therapeutic Vaccine 70 Partial Onset Seizures 70 Hematopoietic Stem Cell Transplantation 70 Oral Interferon 70 Well Tolerated 70 ACE Inhibitors 70 FDA Clears 70 Antibiotic Use 70 Fracture Risk 70 Protease Inhibitor 70 Phase III Clinical Trial 70 Successfully Completes Phase 70 Metastatic Prostate Cancer 70 Anti Inflammatory Drug 70 Arthritis Drugs 70 Effectively Treats 70 Hepatitis C Patients 70 Successfully Treated 70 Genetic Tests 70 Tuberculosis Vaccine 70 Experimental Vaccine 70 Submits NDA 70 Estrogen Therapy 70 JAK Inhibitor 70 Anti Clotting Drug 70 Pneumococcal Conjugate Vaccine 70 Treatment Naive 70 Pregnancy Linked 70 Inhaled Corticosteroids 70 Calcium Supplements 70 Shows Promise Against 70 Lung Cancer Survival 70 Higher Doses 70 Bacterial Infection 70 Statistically Significant 70 Topical Cream 70 NDA Submission 70 Significantly Reduced 70 Conjugate Vaccine 70 Inhaled Nitric Oxide 69 Treatment Reduces 69 Investigational Drug 69 Hepatitis C Virus 69 Patients Undergoing 69 Fast Track Status 69 Swine Flu Vaccine 69 Dose Ranging Study 69 Antibiotic Treatment 69 Resistant Hypertension 69 Kidney Function 69 Antifungal 69 Pivotal Trials 69 MMR Vaccine 69 Oral Insulin 69 Expanded Indication 69 Liver Damage 69 Lower Blood Pressure 69 Shows Promising 69 Hepatitis B Virus 69 Migraine Treatment 69 MRSA Infections 69 Artery Disease 69 Antipsychotic Medications 69 Initiate Clinical Trial 69 Demonstrates Potent 69 Adjuvant Chemotherapy 69 Diabetic Nephropathy 69 Cancer Treatments 69 SFDA Approval 69 Adjunctive Therapy 69 Effectively Treat 69 Weight Loss Pill 69 Slows Progression 69 Complicated Skin 69 Serious Infections 69 Protein Linked 69 Contaminated Heparin 69 Increased Mortality 69 Myelodysplastic Syndromes 69 Patients Suffering 69 Human Monoclonal Antibody 69 Diet Pill 69 Peginterferon 69 Study Showed 69 Prostate Cancer Patients 69 Knee Osteoarthritis 69 Metabolic Disorder 69 Test Detects 69 Respiratory Virus 69 Vaccine Adjuvant 69 Insulin Glargine 69 Genes Linked 69 Drug Prevents 69 Autoimmune Disease 69 Respiratory Syncytial Virus RSV 69 Antibiotic Resistant 69 Prophylactic Treatment 69 Node Positive 69 Bazedoxifene 69 Prostate Cancer Treatment 69 Ovarian Cancer Patients 69 Gene Therapy Trial 69 NICE Recommends 69 Acne Drug 69 Initiates Clinical 69 Obese Patients 69 Blood Pressure Drugs 69 Advanced Prostate Cancer 69 Topical Treatment 69 Haemophilus b Conjugate 69 Impotence Drug 69 Breast Cancer Recurrence 69 Anti Tumor 69 Advisers Urge 69 Adjuvanted 69 Ebola Vaccine 69 Pivotal Study 69 Novel Treatments 69 Peanut Allergy 69 Genes Identified 69 Prevent Stroke 69 Community Acquired Pneumonia 69 Receptor Agonist 69 Receives Approvable Letter 69 Monoclonal Antibody 69 Androgen Deprivation Therapy 69 Chronic Sinusitis 69 Initiate Phase 69 Pain Medication 69 Treatment Naive Patients 69 Genetic Mutation 69 Serious Side Effects 69 Whooping Cough Vaccine 69 Unfractionated Heparin 69 Demonstrates Significant 69 Fixed Dose 69 Critically Ill Patients 68 Heart Failure Patients 68 Synthetic Peptide 68 Patients Receiving 68 Improve Diagnosis 68 Patients Treated 68 Preterm Delivery 68 Guidelines Recommend 68 Treatment Naive HIV 68 Therapeutic Vaccines 68 Beta Blocker 68 Weight Loss Supplement 68 Phase 2a Clinical Trial 68 Hepatitis C Genotype 68 Predict Response 68 Diabetic Neuropathy 68 Vaccine Trial 68 Hormone Refractory Prostate Cancer 68 Phase IIb Clinical Trial 68 Treatment Regimen 68 Initiates Phase III 68 Commonly Prescribed 68 Novel Mechanism 68 Confirms Efficacy 68 Alternative Treatments 68 Elderly Patients 68 Pneumonia Vaccine 68 Receives Positive Opinion 68 Therapeutic Efficacy 68 Brain Cells 68 Is Well Tolerated 68 Fluconazole 68 Universal Flu Vaccine 68 Renal Cancer 68 Enlarged Prostate 68 Kidney Transplants 68 Completes Enrollment 68 Tumor Targeting 68 HER2 Positive 68 Oral Fingolimod 68 Anemia Drugs 68 Files IND 68 Relapsed Refractory 68 Lung Cancer Trial 68 Kidney Failure 68 Severe Asthma 68 Peginterferon Alfa 2a 68 Lupus Nephritis 68 Commonly Used 68 Help Smokers Quit 68 Treatment Experienced 68 Phase III Clinical Trials 68 HCV Protease Inhibitor 68 Novel Therapeutic 68 Drug Resistant Bacteria 68 Dengue Virus 68 Lanthanum Carbonate 68 Cold Medicines 68 Counterfeit Drugs 68 Disease Modifying 68 Study Casts Doubt 68 Protein Involved 68 Phase IIa Clinical Trial 68 Gastric Ulcers 68 Bacterial Infections 68 Hospital Acquired Pneumonia 68 Generic Version Of 68 Reduces Mortality 68 Colorectal Adenomas 68 Avian Influenza Vaccine 68 Shown Effective 68 Fondaparinux 68 Osteoarthritis Patients 68 Gene Mutation 68 Anthrax Vaccine 68 Atypical Antipsychotics 68 Immune Responses 68 Efficacy Trial 68 Gene Linked 68 Kidney Transplant Recipients 68 Immunosuppressant 68 Postmenopausal Osteoporosis 68 Protease Inhibitors 68 Inflammatory Arthritis 68 PRN FDA Approves 68 Randomized Double Blind 68 Breathing Problems 68 Insulin Resistance 68 Stomach Cancer 68 Renal Function 68 Demonstrates Statistically Significant 68 Abortion Pill 68 Vaginal Gel 68 II Clinical Trial 68 Vaccine Prevents 68 Chronic Hepatitis C 68 Gastrointestinal Disorders 68 Potentially Deadly 68 Trial Evaluating 68 Vitamin Supplements 68 Genital Warts 68 Positive Opinion 68 Atypical Antipsychotic 68 FDA Warns 68 Effective Than 68 Live Attenuated Influenza Vaccine 68 Drug Coated Stents 68 Genetic Variant 68 HPV Vaccine Gardasil 68 Viral Infections 68 Ear Infections 68 Hepatitis C Treatment 68 Initiates Clinical Trial 68 Psoriasis Patients 68 Maleate 68 Could Prevent 68 Prevent Breast Cancer 68 Pegylated Interferon 68 Controlled Study 67 Herpes Virus 67 Systemic Delivery 67 Virus Infection 67 Reduces Risk 67 Antiplatelet 67 Heart Defects 67 Chemotherapy Regimen 67 Non Invasive Treatment 67 Levels Linked 67 Neuroprotective Effects 67 Schizophrenia Treatment 67 Multicenter Trial 67 Immunogenicity 67 Drug Coated Stent 67 Improve Outcomes 67 Chemoradiation 67 Relieve Pain 67 Subgroup Analysis 67 Bloodstream Infections 67 Skin Infections 67 Taxane 67 Novel Oral 67 Mouse Model 67 Ample Supply 67 Significantly Improved 67 Randomized Study 67 Benign Prostatic Hyperplasia 67 Amgen Nplate 67 Milestone Payment 67 Sustained Efficacy 67 Renal Impairment 67 Clinically Tested 67 Antipsychotic Drug 67 Treated Patients 67 Unapproved Drugs 67 Viral Infection 67 Doctors Warn 67 Cardiovascular Events 67 STELARA TM 67 Confirmatory Phase 67 Epoetin Alfa 67 Bone Marrow Cells 67 Pafuramidine 67 Bosutinib 67 Testosterone Patch 67 Lowers Blood Pressure 67 Treatment Regimens 67 Hormone Therapy 67 Recurrent Breast Cancer 67 Previously Untreated 67 Present Preclinical Data 67 Blood Clot Risk 67 Clinical Outcome 67 Fabry Disease 67 Metastatic Melanoma 67 See CLINICAL PHARMACOLOGY 67 Breast Cancer Cells 67 Bowel Disease 67 Muscle Wasting 67 Papillomavirus 67 Combination Therapy 67 Teva Provides Update 67 Inflammatory Diseases 67 Tumor Growth 67 Pivotal Phase III 67 Liver Injury 67 Therapeutic Potential 67 Develop Novel 67 Oral Contraceptive 67 Preclinical Models 67 Molecular Diagnostic Test 67 Cold Meds 67 Tigecycline 67 Genetic Variations 67 Breast Cancer Treatment 67 C1 Inhibitor 67 Clostridium difficile Infection 67 Childhood Vaccine 67 Study Shows Promise 67 Stakeholder Opinions 67 Cardiovascular Outcomes 67 Initiates Phase II 67 TNF Blockers 67 Premature Babies 67 Medication Errors 67 Clinical Trial Data 67 Ovarian Cancer Treatment 67 Prevent Spread 67 Antidepressant Use 67 Pivotal Phase 67 Nitazoxanide 67 Low Dose 67 Allergic Rhinitis 67 Prostate Tumors 67 Therapy Shows Promise 67 Antipsychotic 67 Prostate Surgery 67 Chronic Myeloid Leukemia 67 Cognitive Impairment 67 Contrast Agents 67 Thyroid Hormone 67 Prospective Randomized 67 Cancer Vaccine 67 Plus Ribavirin 67 Adenoma 67 Gene Mutations 67 Cancer Recurrence 67 Respiratory Distress 67 Adverse Effects 67 Short Stature 67 Hospitalization Rates 67 Pneumococcal Disease 67 Increases Risk 67 Gene Variants 67 Urinary Tract Infections 67 Could Save Lives 67 Seasonal Influenza 67 Chronic Renal Failure 67 Newborn Babies 67 Flu Vaccinations 67 Clinical Study Shows 67 Boceprevir 67 Minimally Invasive Treatment 67 Virus Vaccine 67 ORLive Presents 67 Treat Anemia 67 Randomized Controlled Trials 67 Valproic Acid 67 Brain Shrinkage 67 Aggressive Prostate Cancer 67 Randomized Phase 67 Asthma Sufferers 67 Chronic Constipation 67 Therapy Improves 67 Brain Atrophy 67 Novel Vaccine 67 Malignant Melanoma 67 PDUFA Date 67 Dose Escalation 67 Nanoemulsion 67 Iron Overload 67 Patient Enrollment 67 Acute Heart Failure 67 Cognitive Function 67 FDA Approves 67 Chronic Cough 67 ARIXTRA R 67 Chronic Lymphocytic Leukemia 67 Phase 1b Clinical Trial 67 Vildagliptin 67 Respiratory Syncytial Virus 66 Replacement Therapy 66 Hsp# Inhibitor 66 Pivotal Trial 66 Allergic Asthma 66 Treatment Naïve 66 Dendritic Cells 66 Poster Presentations 66 Relapsing Multiple Sclerosis 66 Montelukast 66 Antidepressants Linked 66 Male Infertility 66 Romiplostim 66 Often Misdiagnosed 66 Anti Tumor Activity 66 Entecavir 66 Neutralizing Antibodies 66 Asthma Symptoms 66 Tipranavir 66 Diabetic Neuropathic Pain 66 Anticancer Agent 66 Granted Orphan Drug 66 Anti Nausea 66 First Patient Dosed 66 Stem Cell Procedure 66 Atopic Dermatitis 66 Transdermal Delivery 66 Inhibits 66 Allogeneic 66 Interferon Beta 66 Virus Linked 66 Migraine Headaches 66 Predict Risk 66 Help Detect 66 IIa Clinical Trial 66 Be Cured 66 Faropenem 66 Peripheral Blood 66 Breast Cancers 66 Vitamin D Deficiency 66 Blood Stem Cells 66 Sleep Disturbances 66 Kidney Stones 66 Viral Load 66 Cholesterol Levels 66 Herbal Supplements 66 Bird Flu Pandemic 66 Tablet Formulation 66 Anticancer Activity 66 Capsules CII 66 Advanced Ovarian Cancer 66 Symptom Relief 66 Statin Therapy 66 Clinical Efficacy 66 Topical Gel 66 Somatostatin 66 Iron Deficiency 66 Carboplatin Paclitaxel 66 Adalimumab 66 Surgery Performed 66 Contrast Agent 66 Prostate Cancers 66 ORENCIA ® 66 Antiretrovirals 66 Nasal Powder 66 Diagnosis Treatment 66 Oral Cladribine 66 Elevated Levels 66 Preclinical Data 66 Peanut Allergies 66 Small Molecule 66 Phase 2b Study 66 Hip Implants 66 Immunotherapeutic 66 Colorectal Cancer Risk 66 Herbal Extract 66 Endometrial Cancer 66 Tumor Suppressor Gene 66 SARS Virus 66 Desvenlafaxine Succinate 66 Flu Viruses 66 Help Diagnose 66 Atomoxetine 66 Tezampanel 66 Meningococcal Disease 66 Eur J 66 Stem Cell Treatments 66 Immunologic 66 Ischemic Stroke 66 Cough Medicines 66 Survival Rates 66 Monoclonal Antibodies 66 Gum Disease 66 Diabetic Kidney Disease 66 Being Studied 66 Study Evaluates 66 Therapeutic Effects 66 Integrase Inhibitor 66 Inactivated 66 Oral Calcitonin 66 Diamyd Medical Diamyd 66 Venous Thromboembolism 66 Liver Tumors 66 Tyrosine Kinase Inhibitor 66 Prove Effective 66 Respiratory Infections 66 Blood Vessels 66 VIVUS Qnexa 66 Contaminant Found 66 Urinary Incontinence 66 Breast Cancer Genes 66 Adjuvant Therapy 66 Genes Predict 66 IND Filing 66 Neoadjuvant Chemotherapy 66 Seasonal Allergies 66 HER2 Positive Breast Cancer 66 Non Inferiority 66 Receives Marketing Authorization 66 Nebulized 66 Patients Enrolled 66 Premenopausal Women 66 Silicone Breast Implants 66 Anti Inflammatory 66 BioSante Pharmaceuticals Announces 66 Flu Vaccine 66 Impairs 66 Studies Suggest 66 Tesamorelin 66 Pivotal Clinical Trial 66 Showed Significant 66 Obese Teens 66 Childhood Immunizations 66 Drug Makers 66 Quadrivalent 66 Generalized Anxiety Disorder 66 Malignant Glioma 66 Diabetic Foot Ulcer 66 Tiotropium 66 Pandemic Vaccine 66 Moderate Drinking 66 Antiretroviral Drug 66 Decitabine 66 Genetic Disorder 66 Oral Fluid 66 Genes Involved 66 Patent Covering 66 Acute Pancreatitis 66 Monotherapy 66 Fat Cells 66 Pre Eclampsia 66 BioElectronics Announces 66 Leukemia Cells 66 Hemodialysis Patients 66 Demonstrated Significant 66 Drug Resistant Staph 66 Breast Tumors 66 Successfully Treats 66 Nail Fungus 66 Drug Approvals 66 Patient Treated 66 Breast Tumor 66 Abdominal Pain 66 Menopausal Symptoms 66 Blood Transfusions 66 Muscle Function 66 Less Invasive 66 Targeted Therapies 66 Septic Shock 66 Stress Incontinence 66 Angiogenic 66 Streptococcus Pneumoniae 66 Pegylated 66 Bone Fracture 65 Hematological Malignancies 65 FDA Approves Generic 65 Multidrug Resistant 65 Chemotherapeutic Agents 65 Skin Lesions 65 Extended Release 65 Gets FDA Clearance 65 Advanced Pancreatic Cancer 65 HCl Injection 65 Bone Fractures 65 Million Milestone Payment 65 Cardiovascular Disease Risk 65 Calcium Vitamin D 65 Chronic Inflammation 65 Epileptic Seizures 65 Ovary Removal 65 Adefovir 65 Skeletal Muscle 65 Uterine Fibroids 65 Potential Dangers 65 Oral Formulation 65 Prognostic Factors 65 Lopinavir 65 Skin Cells 65 Sagent Pharmaceuticals Announces 65 Long Term Outcomes 65 Melphalan 65 Desvenlafaxine 65 Mg Uk 65 Universal Influenza Vaccine 65 Progressive Multifocal Leukoencephalopathy 65 Receives SFDA Approval 65 Influenza Vaccine Production 65 Donor Organs 65 Immunomedics Announces 65 Tamiflu Resistant 65 Oral Cavity 65 Be Prevented 65 Regimens 65 Oral Anticoagulant 65 Booster Shot 65 Glufosfamide 65 Phase III Pivotal 65 Thromboembolism 65 Artificial Sweeteners 65 Allergic Reaction 65 Cethromycin 65 Reduce Mortality 65 Bird Flu Virus 65 Files Investigational 65 Asthma Attacks 65 Could Detect 65 Cigarette Smoke 65 Localized Prostate Cancer 65 Antiviral Activity 65 Colorectal Cancers 65 Bone Grafting 65 Live Attenuated 65 Randomized Clinical Trial 65 Premature Births 65 Lactose Intolerance 65 Tainted Eggs 65 Kinase Inhibitor 65 Amniotic Fluid 65 Juvenile Idiopathic Arthritis 65 Study Reinforces 65 Gene Variation 65 Neural Stem Cells 65 Taro Receives 65 Double Blind Placebo 65 Soft Tissue Sarcoma 65 Data Indicate 65 Bronchodilator 65 Transplant Recipient 65 Dual Antiplatelet Therapy 65 Cutaneous T 65 Novel Therapies 65 Adversely Affect 65 Lung Transplants 65 Increased Risk 65 Breast Cancer Metastasis 65 Pandemic Influenza Vaccines 65 Moxifloxacin 65 Meta Analysis 65 Merck Suspends Lobbying 65 Liver Toxicity 65 Cases Linked 65 Aliskiren 65 Clinically Significant 65 Wound Dressings 65 Therapeutic Agents 65 Lung Injury 65 Mouse Models 65 Plaque Psoriasis 65 Lipid Levels 65 Reduces Pain 65 Botulinum Toxin 65 Spinal Fusion 65 Lung Cancers 65 Low Doses 65 Initiate Phase III 65 Silicone Implants 65 Systematic Review 65 Kinase Inhibitors 65 Autoimmune Disorders 65 Eye Infections 65 Brain Metastases 65 Vicriviroc 65 Lung Tumors 65 Achieves Primary Endpoint 65 Lung Infections 65 Telbivudine 65 Injection Site 65 Newly Diagnosed Patients 65 Skin Condition 65 Completes Dosing 65 Advanced Renal Cell 65 Novel Compound 65 Parainfluenza 65 Controlled Trial 65 Fibromyalgia Pain 65 Lymphoma Patients 65 Pramlintide 65 Long Term Survival 65 Preclinical Study 65 Mesalamine 65 Genetically Engineered Salmon 65 Stem Cell Transplants 65 Study Compares 65 Prostate Screening 65 Antiretroviral Therapy 65 Parenteral Nutrition 65 Therapeutic Monoclonal Antibodies 65 Initiates Enrollment 65 Pain Medications 65 Disease Progression 65 Male Contraceptive 65 Subtypes 65 Carotid Stenting 65 Flu Symptoms 65 Flu Spreads 65 Levoleucovorin 65 Leukemias 65 Glucose Levels 65 Demonstrates Positive 65 Asthma Medication 65 Cold Sores 65 Artificial Pancreas 65 Blood Cancers 65 Cancer Vaccines 65 Urine Test 65 Brain Scans 65 Embryonic Stem Cells 65 Prevent Prostate Cancer 65 Hematological Cancers 65 Epidermal Growth Factor Receptor 65 Vaccine Doses 65 Immune Cell 65 Genes Associated 65 Biosimilar 65 Immunosuppression 65 Interferon Gamma 65 Immune Therapy 65 Novel Method 65 Inflammatory Disease 65 Insulin Sensitivity 65 Demonstrates Potential 65 Unresectable 65 Antimicrobial Coating 65 Antibacterials 65 Lung Cancer Treatment 65 Environmental Toxins 65 Neuroprotection 65 Critically Ill 65 Tyrosine Kinase Inhibitors 65 Double Blind Randomized 65 Brain Tumors 65 Skin Cancers 65 Treatable 65 Pegloticase 65 Levofloxacin 65 Attenuates 65 Suicidality 65 Bone Marrow Transplants 65 Vaccine Adjuvants 65 First Patient Enrolled 65 Cell Proliferation 65 Wound Dressing 65 Cervical Dysplasia 65 Prostate Cancer Survival 65 Mimetics 65 Azathioprine 65 Parathyroid Hormone 65 Menopausal Women 65 Dasatinib 65 FDA Cracks Down 65 Hip Fractures 65 Sustained Release 64 Effective Treatments 64 Maribavir 64 Chemotherapy Induced Nausea 64 Overweight Obese 64 Initiates Clinical Trials 64 Inhalable 64 Randomized Trials 64 Pirfenidone 64 Healthbeat Report 64 Preterm Labor 64 Liver Transplant Patients 64 Placebo Controlled Trial 64 Acellular Pertussis 64 Epoetin 64 Diet Linked 64 Preterm Infants 64 Study Demonstrates 64 Genetic Mutations 64 Aflibercept 64 Arterial Disease 64 Treatment Naïve Patients 64 Hormone Replacement 64 Bioequivalence 64 ONGLYZA TM 64 Immune Response 64 Smooth Muscle 64 Drug Eluting 64 FDA APPROVES 64 Panic Disorder 64 Anthracycline 64 Begins Dosing 64 Confirmed Cases 64 Systemic Sclerosis 64 Hormone Receptor Positive 64 Bacterial Vaginosis 64 Cancer Screenings 64 Non Responders 64 Medoxomil 64 Corneal Transplant 64 Interferon Alfa